-
Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
Cons
Performance of Advanced Proteome Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | 2.000% | -0.488% | -7.692% | 105.025% | 22.892% | 9.677% | -66.281% |
| Celldex Therapeutics | -8.820% | -8.824% | -2.362% | 61.039% | 12.727% | -23.786% | 42.939% |
| Achieve Life Sciences Inc. | 8.270% | 10.722% | -29.062% | 17.763% | -27.432% | -54.684% | -72.462% |
News
2 AI Stocks That Survived the March Sell-Off -- and Look Stronger Because of It
The March sell-off hit even the hottest areas of technology. However, not every tech stock was down for the month, and one pair of stocks in particular stood out as not only surviving the sell-off
AMD vs. Nvidia: The AI Supercycle Is Big Enough for Both. Here's the Better Buy.
The artificial intelligence (AI) boom is creating massive winners, but not every stock riding this wave will deliver the same type of returns for investors.
Nvidia (NASDAQ: NVDA) and Advanced Micro
Stock Market Today, April 2: Markets Muted on Mixed Iran War Reports
Oil and geopolitics remained firmly in focus before markets closed for Good Friday. The S&P 500 (SNPINDEX:^GSPC) rose 0.11% to 6,582.69, finishing the week up 1.63%. The Nasdaq Composite (NASDAQINDE


